In 2014, the Wisconsin Alzheimer's Disease Research Center received a five-year grant from the NIH totalling $7.5M dollars. The center was the first of its kind, created in 2009, and has provided a focused place of research on Alzheimer's diagnosis and treatment. With funding through March of 2019, the center is moving forward, with one recent publication indicating a panel of biomarkers that have been linked with Alzheimer's.Read More
Science Market Update
“As many as 5 million Americans face the challenge of Alzheimer’s disease, which robs them of their memories, their independence, and ultimately, their lives. We are determined, even in a time of constrained fiscal resources, to capitalize on exciting scientific opportunities to advance understanding of Alzheimer’s biology and find effective therapies as quickly as possible.”
Researchers at Georgetown University conducted a study that suggests that undiagnosed pre-diabetes occurs at higher rate than was previously thought in people with Alzheimer’s disease. Dr. R. Scott Turner, director of the Georgetown University Medical Center’s Memory Disorders Program, brought people into the study who had mild to moderate Alzheimer’s disease so that he could investigate resveratrol, a compound found in red grapes and red wine. Resveratrol is thought to mimic the effects of a low calorie diet. When the study began, Dr. Turner said he was shocked by how many of the study’s participants had pre-diabetes.